Clincosm LogoSign in Get a demo

recurrent breast carcinoma

Showing 1 - 25 of 64
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
Has Results
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)

Active, not recruiting
Has Results
  • HER2/Neu Positive
  • +8 more
  • Anniston, Alabama
  • +1291 more
Jan 28, 2023

Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

Active, not recruiting
Has Results
  • Invasive Breast Carcinoma
  • +3 more
  • Bevacizumab
  • +4 more
  • Mobile, Alabama
  • +525 more
Jan 28, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Blood and Tumor Samples From Advanced or Metastatic Estrogen

Active, not recruiting
  • Advanced Breast Carcinoma
  • +8 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,

Active, not recruiting
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • +7 more
  • Birmingham, Alabama
  • +499 more
Nov 15, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 22, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Advanced Triple-Negative Breast Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Birmingham, Alabama
  • +9 more
Aug 31, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Metastatic BRCA-Associated Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in

Active, not recruiting
  • Metastatic BRCA-Associated Breast Carcinoma
  • +5 more
  • Anchorage, Alaska
  • +815 more
Aug 5, 2022

HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,

Completed
Has Results
  • HER2-Positive Breast Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +301 more
Jun 28, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Metastatic Breast Carcinoma Trial in Buffalo (Informational

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Informational Intervention
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 14, 2022

Cognitive Side Effects of Cancer Therapy, Depression, Recurrent Breast Carcinoma Trial in Columbus (typhoid vaccine, Placebo)

Active, not recruiting
  • Cognitive Side Effects of Cancer Therapy
  • +7 more
  • typhoid vaccine
  • Placebo
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
Apr 20, 2022

Metastatic Breast Adenocarcinoma, Metastatic HER2-Positive Breast Carcinoma, Recurrent Breast Adenocarcinoma Trial in Canada,

Recruiting
  • Breast Adenocarcinoma
  • +8 more
  • Birmingham, Alabama
  • +667 more
Apr 6, 2022

Breast Cancer, Breast Adenocarcinoma, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Bronx (Rebastinib,

Terminated
  • Breast Cancer
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
Mar 23, 2022

HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle

Recruiting
  • HER2 Negative Breast Carcinoma
  • +6 more
  • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 18, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic Breast Adenocarcinoma Trial in Rochester

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 2, 2022

Breast Adenocarcinoma, HER2/Neu Negative, Locally Advanced Breast Carcinoma Trial in South Africa, United States (Entinostat,

Active, not recruiting
Has Results
  • Breast Adenocarcinoma
  • +9 more
  • Birmingham, Alabama
  • +662 more
Oct 18, 2021

Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Tumor in the Brain Trial in Worldwide (Carvedilol, Laboratory Biomarker

Recruiting
  • Cardiotoxicity
  • +4 more
  • Anchorage, Alaska
  • +579 more
Nov 8, 2021

Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in United States (Endoxifen

Active, not recruiting
Has Results
  • Recurrent Breast Carcinoma
  • +5 more
  • Endoxifen Hydrochloride
  • +3 more
  • Mobile, Alabama
  • +566 more
Sep 1, 2021

Estrogen Receptor Positive, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in Seattle (procedure, drug,

Terminated
Has Results
  • Estrogen Receptor Positive
  • +2 more
  • Computed Tomography
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 28, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in

Withdrawn
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021